GuidelineBJU international2026

Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer.

Abdullah Al-Khanaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.